Product
Quadrivalent inactivated influenza vaccine
Aliases
Quadrivalent inactivated influenza vaccine (IIV)
3 clinical trials
1 indication
Indication
InfluenzaClinical trial
A Phase III Randomized, Modified Double-blind, Active-controlled, Multi-center Study to Describe the Immunogenicity and Safety of the Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South KoreaStatus: Completed, Estimated PCD: 2022-09-01
Clinical trial
Response to Inactivated Influenza Vaccine in Lymph Tissue and BloodStatus: Withdrawn, Estimated PCD: 2023-11-17
Clinical trial
Response to Influenza Vaccine During PregnancyStatus: Completed, Estimated PCD: 2023-12-31